Clinical Trials | May 09, 2023
Briefs: Krsnaa Diagnostics
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
The collaboration between CORONA and Ferring will cater to patients across India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
New agreement applies to the polymers of the Medical Care series portfolio
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Subscribe To Our Newsletter & Stay Updated
